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Abstract Cell differentiation is controlled by individual transcription factors (TFs) that together
activate a selection of enhancers in specific cell types. How these combinations of TFs identify and
activate their target sequences remains poorly understood. Here, we identify the cis-regulatory
transcriptional code that controls the differentiation of serotonergic HSN neurons in
Caenorhabditis elegans. Activation of the HSN transcriptome is directly orchestrated by a collective
of six TFs. Binding site clusters for this TF collective form a regulatory signature that is sufficient for
de novo identification of HSN neuron functional enhancers. Among C. elegans neurons, the HSN
transcriptome most closely resembles that of mouse serotonergic neurons. Mouse orthologs of the
HSN TF collective also regulate serotonergic differentiation and can functionally substitute for their
worm counterparts which suggests deep homology. Our results identify rules governing the
regulatory landscape of a critically important neuronal type in two species separated by over 700
million years.
DOI: https://doi.org/10.7554/eLife.32785.001
Introduction
Cell identities are characterized by the expression of specific transcriptomes that are activated
through cell-type-specific regulatory landscapes. Large efforts have been made to identify functional
enhancers in different tissues and developmental stages. The approaches include the occupancy of
combinations of transcription factors (TFs), identifying DNA regions displaying open chromatin
states, analyzing specific histone marks and assessing enhancer function by transgenesis in vivo
(Junion et al., 2012; Mo et al., 2015; Nord et al., 2013; Pattabiraman et al., 2014; Visel et al.,
2013; Zinzen et al., 2009). These studies have revealed a highly dynamic organization of active
enhancers that change depending on the cell type and developmental stage. However, to date, it is
unclear what features of the DNA sequences distinguish enhancer regions from the rest of the
genome. The identification of such features is critical both for understanding fundamental biological
processes such as cell fate specification, as well as for biomedicine, given that most disease-associ-
ated mutations are thought to be located within regulatory sequences (Mathelier et al., 2015;
Nishizaki and Boyle, 2017).
TFs are the main regulators of enhancer function. Each enhancer is bound by specific combina-
tions of TFs that will either activate or repress transcription (Reiter et al., 2017). The distribution of
TF-binding sites (TFBS) has been studied in detail in only a few enhancers. For example, a study of
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sparkling, a specific enhancer of the Drosophila Pax2 gene, revealed it to be densely packed with
TFBS that required specific arrangements for its functionality (Swanson et al., 2010). However, these
one-by-one approaches are not able to reveal any general molecular logic underlying cell-type-spe-
cific regulatory landscapes. Chromatin immunoprecipitation combined with deep sequencing (ChIP-
seq) has been used to generate genome-scale binding profiles of specific TFs. It is now clear that
TF-binding profiles are dynamic during cell differentiation and vary in related species (Garber et al.,
2012; Heinz et al., 2010; Khoueiry et al., 2017; Nord et al., 2013; Stefflova et al., 2013;
Wilczyn´ski and Furlong, 2010; Zinzen et al., 2009). However, it is unclear what distinguishes TFBS
actually bound by the TF from those that are unoccupied. Moreover, despite the fact that only a
small fraction of bound TFBS are located in enhancers (Kwasnieski et al., 2014;
Pattabiraman et al., 2014; Whitfield et al., 2012), the molecular organization that distinguishes
functional enhancers from the rest of non-coding regions is still unknown. Collective binding of sev-
eral TFs is emerging as an important feature that distinguishes TFBS at functional enhancers from
other genomic regions bound by individual TFs (Junion et al., 2012; Khoueiry et al., 2017;
Mazzoni et al., 2013; Zinzen et al., 2009). However, it is still unclear how these combinations of
TFs are collectively recruited to and activate cell-type-specific regulatory landscapes.
The study of the transcriptional regulatory mechanisms underlying neuronal subtype specification
in vivo in complex model organisms, such as rodents, is a challenging task. Here, we take advantage
of the simple model organism C. elegans to study neuron type specification in vivo. C. elegans is
especially suitable for transcriptional regulatory studies because its cell lineage is fully described, it is
easy to genetically manipulate and its genome is very compact (despite containing a similar number
of genes to the human genome) (Gerstein et al., 2010). In this work, we focus on the study of the
transcriptional regulatory logic of serotonergic neurons. Serotonergic neurons are present in all
eumetazoan groups and are universally defined by their ability to synthesize and release serotonin
eLife digest All cells in the body essentially share the same DNA, despite looking very different
and playing a range of roles. The reason that cell types are so different from one another is because
of the way they interpret the DNA. Each different type of cell uses a specific subset of the genes
within the genome. The part of the DNA that controls which cell will use which genes and when is
called the regulatory genome; this DNA is not translated into proteins.
The regulatory genome is much less well understood than the protein-coding genome. At
present, when a new species is discovered, it is often possible to sequence its DNA and deduce
where the protein-coding genes are and what roles they might play. However, it is not yet possible
to do the same for the regulatory genome. Finding a way to do this is an important step towards
understanding when and where each of the organism’s genes is active.
Lloret-Ferna´ndez, Maicas, Mora-Martinez et al. focused on the regulatory genome of nerve cells
that use a chemical messenger called serotonin in the nematode worm Caenorhabditis elegans.
First, they studied mutations in six genes that code for transcription factors that are active in this cell
type. Transcription factors are proteins that identify and bind to specific regions of the genome to
control the activity of nearby genes. These six mutants failed to correctly activate the regulatory
genome of this nerve cell, which was measured using a genetic approach that caused the nerves to
glow green under a microscope when the regulatory genome was active.
Further experiments then confirmed that all six transcription factors must act together to identify
and activate the regulatory genome in this particular nerve cell. The fact that the DNA sites that
these transcription factors bind are clustered close to each other means they can be used as a
marker to help decode the active regulatory genome of this class of nerve cell.
This is a small step towards understanding how the regulatory genome works. Comparisons with
similar nerve cells from mammals found that the equivalent transcription factors have the same role,
suggesting that they may be broadly conserved across species. Understanding the regulatory
genome better could eventually lead to new treatments for certain genetic conditions, as many
mutations associated with diseases appear outside the protein-coding genome.
DOI: https://doi.org/10.7554/eLife.32785.002
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(5HT) (Flames and Hobert, 2011). They regulate multiple processes and their dysfunction has been
linked to bipolar disorder, depression, anxiety, anorexia and schizophrenia (Deneris and Wyler,
2012; Mathelier et al., 2015). Several TFs are known to be involved in mammalian serotonergic dif-
ferentiation (Deneris and Wyler, 2012). However, little is known about their function in the regula-
tion of specific serotonergic neuron enhancers. Here, we focus on this clinically relevant and highly
conserved neuronal subtype, and exploit the amenability of C. elegans to unravel the rules govern-
ing the activation of the serotonergic transcriptome. This work reveals the phylogenetically con-
served action of a collection of TFs on the selection of a specific regulatory landscape from the
genome and allows for the identification of neuron subtype specific functional enhancers merely
based on the presence of the TF collective regulatory signature.
Results
Transcription factors from six different families are required for HSN
neuron terminal differentiation
Serotonergic neurons are characterized by the coordinated expression of a battery of phylogeneti-
cally conserved enzymes and transporters known as the 5HT pathway genes (Figure 1A). C. elegans
adult hermaphrodites contain three functionally distinct serotonergic neuron subclasses: the NSM
neurosecretory neuron, the ADF chemosensory neuron and the HSN motor neuron (Figure 1B),
which arise from different progenitors and, with the exception of the 5HT pathway genes, express
different effector genes (Figure 1—figure supplement 1). The HSN neuron is, by far, the best char-
acterized, thus we focused on dissecting the transcriptional rules governing the differentiation of this
subclass.
The HSN motor neuron controls vulval muscle contraction and its dysfunction leads to an egg lay-
ing defective (egl) phenotype. To identify the TF combination controlling HSN terminal differentia-
tion, we selected among previously described egl mutants, those that both code for TFs and had
reduced or no staining of 5HT in HSN. At least four genes matched this criteria: the POU domain TF
unc-86, the Spalt-type Zn finger TF sem-4, the bHLH domain TF hlh-3 and the Insm-type Zn finger
TF egl-46 (Basson and Horvitz, 1996; Doonan et al., 2008; Sze et al., 2002; Wu et al., 2001). In
addition to previous reports, we found that the GATA factor egl-18, a regulator of HSN migration
(Desai et al., 1988) and the ETS TF ast-1, a regulator of dopaminergic fate (Flames and Hobert,
2009), also exhibit an HSN 5HT staining phenotype not previously published. Thus, although addi-
tional TFs with subtler egl phenotypes or with pleiotropic lethal effects and no available hypomor-
phic alleles are likely to be required for correct HSN differentiation, we initially focused our study in
this set of six TFs that we refer as the HSN TF combination.
To confirm previous observations, we analyzed null alleles for each member of the HSN TF combi-
nation except for ast-1, where we used a hypomorphic allele as the null allele is lethal prior to HSN
differentiation (Schmid et al., 2006). All TF mutants indeed displayed a defective egg laying pheno-
type and 5HT staining and 5HT pathway gene expression defects, further supporting their roles in
HSN differentiation (Figure 1C,E and Source data 1). We observed similar 5HT staining and 5HT
pathway gene expression defects by RNAi knock down and in the analysis of additional mutant
alleles for each candidate TF confirming that the phenotype is due to mutations in each correspond-
ing TF and not to background strain effects (Figure 1—figure supplement 2 and
Supplementary file 1). Importantly, 5HT pathway gene expression defects were specific for the HSN
serotonergic subclass, while ADF and NSM neurons were unaffected (Source data 1), the exception
being unc-86(n846) which showed a previously reported NSM differentiation phenotype (Sze et al.,
2002; Zhang et al., 2014).
We next assessed whether the HSN TF combination is also required for the expression of non-
5HT related genes by analyzing nine additional reporters. We observed expression defects in all
mutant strains (Figure 1D,E and Source data 1). Although most terminal features were affected, the
expression of some genes remained normal indicating that, in each single mutant, HSN neuron is
present and shows broad but partial differentiation defects (Figure 1D,E). HSN neuron is born
embryonically and remains in a quiescent undifferentiated state until fourth larval stage (L4), when it
activates the expression of most effector genes, including the 5HT pathway genes. We did not
observe precocious expression of any of the analyzed terminal features in any of the single mutant
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backgrounds, suggesting that the HSN TF combination acts mainly as activator of transcription.
Most notably, the phenotypic profile of each mutant was slightly different from the others, which
suggests that these TFs do not function in a cascade-like linear pathway (Figure 1E).
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Figure 1. Transcription factors from six different TF families are required for HSN terminal differentiation. (A) Phylogenetically conserved serotonin
biosynthetic pathway. C. elegans protein names appear in black case, mammalian in grey. AADC: aromatic L-amino acid decarboxylase; GCH: GTP
cyclohydrolase; TPH: tryptophan hydroxylase; Trp: tryptophan; VMAT: vesicular monoamine transporter; 5HTP: 5-hydroxytryptophan; 5HT: serotonin. (B)
C. elegans hermaphrodite serotonergic system is composed of three subclasses of bilateral neurons (NSM, ADF and HSN, L: left, R: right). See
Figure 1—figure supplement 1 for expression profiles of serotonergic subclasses. (C) Micrographs showing HSN 5HT staining and tph-1::gfp reporter
expression defects of ast-1(ot417), unc-86(n846), sem-4(n1971), hlh-3(tm1688), egl-46(sy628) and egl-18(ok290) mutant animals (quantified in E). Scale
bar: 5 mm. (D) Micrographs showing expression defects in the K+/Cl- cotransporter kcc-2::gfp reporter, a terminal feature of HSN not related to 5HT
signaling, and normal expression of the extracellular matrix gene kal-1, indicating HSN is still present. (E) Heatmap summary of single TF mutant
characterization. Statistically significant expression defects compared to wild type are indicated with a black frame. flp-19: FMRF-like peptide; ida-1: Tyr
phosphatase-like receptor; lgc-55: amine-gated Cl- channel; nlg-1: neuroligin; rab-3: ras GTPase; unc-17: vesicular acetylcholine transporter; unc-40:
netrin receptor. n.a: not analyzed. See Source data 1 for primary data and Fisher’s exact test p-values and Figure 1—figure supplement 2 and
Supplementary file 1 for analysis of additional alleles. n > 100 cells per condition.
DOI: https://doi.org/10.7554/eLife.32785.003
The following figure supplements are available for figure 1:
Figure supplement 1. Each serotonergic neuron subclass expresses different sets of genes.
DOI: https://doi.org/10.7554/eLife.32785.004
Figure supplement 2. Schematic representation of analyzed HSN TF combination alleles.
DOI: https://doi.org/10.7554/eLife.32785.005
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AST-1 acts as temporal switch for HSN maturation
The expression of the HSN TF combination has only been partially studied (Basson and Horvitz,
1996; Doonan et al., 2008; Finney et al., 1988; Wu et al., 2001). We used fosmid reporter strains
(for unc-86, sem-4 and egl-18), endogenous locus tagging (for ast-1 and hlh-3, Figure 2—figure sup-
plement 1) and a transcriptional reporter strain (for egl-46) to analyze their expression pattern in
HSN throughout development. We find that all six TFs are expressed in the HSN at L4 coinciding
with the onset of differentiation (Figure 2A). The HSN TF combination is also expressed in other
neurons, including expression of UNC-86, EGL-18 and EGL-46 in the NSM serotonergic neuron,
while none of them are expressed in the ADF serotonergic neuron.
A deeper analysis of the developmental expression of each TF shows a very diverse array of
expression dynamics (Figure 2B). Some HSN TFs are expressed embryonically (such as UNC-86,
HLH-3 or EGL18). SEM-4 is widely expressed in the embryo in the area were HSN is located,
although it is likely to be expressed at this early stage in HSN, we could not unequivocally identify it.
In contrast, AST-1 and EGL-46 initiate their expression at different postnatal stages (Figure 2B).
Interestingly, HLH-3 shows two waves of expression: it is present in the mother cell of HSN (around
280 min of embryonic development, see lineage in Figure 2—figure supplement 1) and its expres-
sion becomes fainter in postmitotic HSN and PHB neurons (data not shown). At first larval stage (L1),
HLH-3 expression is undetectable in HSN and expression reappears at third larval stage (L3), preced-
ing AST-1 onset of expression and HSN maturation and is quickly downregulated at the end of L4
[Figure 2B, Figure 2—figure supplement 1 and (Doonan et al., 2008)].
Thus, to further study the temporal requirements of HLH-3 activity in HSN differentiation, we
induced HLH-3 expression at early L4 state in hlh-3 mutants. This late expression is sufficient to res-
cue tph-1 reporter expression defects indicating that embryonic HLH-3 expression is not required
for correct HSN terminal differentiation (Figure 2C).
Little is known about the temporal control of HSN differentiation. Heterochronic genes have been
described to regulate the onset of HSN axon extension (Olsson-Carter and Slack, 2010), although
the molecular mechanisms underlying this process are unknown. AST-1 and HLH-3 expression corre-
lates with HSN maturation suggesting they might have a role in determining the onset of this pro-
cess. We used an early active HSN promoter to induce ast-1 and hlh-3 expression precociously from
first larval stage (L1). Our results show that AST-1 significantly advances tph-1 expression to L2-L3
larval stages (Figure 2D). On the contrary, early hlh-3 induced expression either alone or in combina-
tion with ast-1 leads to both a delay in onset and expression defects of tph-1 reporter gene
(Figure 2D). Despite tph-1 expression defects, HSN was still present as we could identify it by differ-
ential interference contrast (DIC) (data not shown). These results suggest that AST-1 activity is an
important determinant of HSN maturation onset. We also found that lin-41 heterochronic mutants
show ast-1 expression defects in the HSN (data not shown) further supporting the role of AST-1 as a
downstream effector controlling HSN maturation timing.
Additionally, these experiments underscored the importance of the dynamic regulation of hlh-3
expression. HLH-3 is a proneural TF of the asc family, ortholog of mouse Ascl1 and Drosophila Scute
(Figure 2—figure supplement 1). Proneural factors regulate both neural progenitor specification
and neuronal differentiation and their functions are conserved through evolution from cnidarians to
mammals (Guillemot and Hassan, 2017). Ascl1 is required for correct mouse serotonergic specifica-
tion (Pattyn et al., 2004) and its activity is required to induce serotonergic fate from human fibro-
blasts (Vadodaria et al., 2016; Xu et al., 2016). HLH-3 shows several features common to ASCL1:
(1) HLH-3 is transiently expressed in all neuronal progenitors and differentiating neuroblasts and it is
required for correct differentiation of several neuronal types, including HSN (Doonan et al., 2008;
Gruner et al., 2016; Krause et al., 1997; Luo and Horvitz, 2017; Murgan et al., 2015). (2) Both
HLH-3 and ASCL1 are required to induce correct neurotransmitter identity (Pattyn et al., 2004;
Sommer et al., 1995). (3) As will be explained in a later section, Ascl1 can rescue HSN differentiation
defects of hlh-3 mutants, supporting its functional conservation. (4) As would be expected for a pro-
neural gene, HLH-3 is also required for correct expression of panneuronal features in the HSN (Fig-
ure 1, rab-3 expression defects). (5) We find that HLH-3 expression needs to be tightly temporally
regulated to correctly induce HSN fate. Temporal regulation of ASCL1 and SCUTE activities is also
required for correct neuronal specification (Andersen et al., 2014; Imayoshi et al., 2013;
Quan et al., 2016; Urba´n et al., 2016). (6) HLH-3 regulates egl-46 expression (discussed in next
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Figure 2. AST-1 acts as temporal switch for HSN maturation. (A) Micrographs showing expression of the HSN TF combination at L4 larval stage and
adult animals. (B) Analysis of HSN TF expression across all developmental stages in the HSN neuron. n > 30 cells for each developmental point. Error
bars are SEP values. See Figure 2—figure supplement 1 for more detailed hlh-3 developmental expression. (C) Heat-shock-induced expression of hlh-
3 at L4 larval stage is able to rescue tph-1::gfp expression defects in the HSN neuron. n > 100 cells per condition. See Source data 1 for primary data
and Fisher’s exact test p-values. *: p-value <0.05. (D) Precocious L1 onset of expression of ast-1, hlh-3 or both using an early active HSN-specific
promoter (also expressed in NSM, ADF and VC4/5 neurons). Precocious ast-1 advances tph-1::gfp expression, while hlh-3 alone or in combination with
ast-1 delays tph-1::gfp expression and produces expression defects. YA: young adult. n > 30 cells per time point and condition. See Source data 1 for
primary data and Fisher’s exact test p-values. *: p-value <0.05.
DOI: https://doi.org/10.7554/eLife.32785.006
The following figure supplement is available for figure 2:
Figure supplement 1. Dynamic HLH-3 expression in the HSN.
DOI: https://doi.org/10.7554/eLife.32785.007
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section, Figure 3A) and similarly, Insm1 (ortholog of egl-46) is a direct target of Ascl1 (Castro et al.,
2011). Taken together, our data suggests that HLH-3 acts as a proneural factor in HSN specification.
Future experiments will determine if, similar to ASCL1 (Wapinski et al., 2013), HLH-3 acts as a pio-
neer factor to facilitate binding of other TFs and promote neural differentiation.
UNC-86 is a master regulator of the HSN transcription factor
combination
We next examined whether these TFs could exhibit cross regulation by analyzing their expression in
each of the six different TF mutant backgrounds. In most cases, expression of each TF was largely
independent of the integrity of the rest of the HSN TFs (Figure 3A and Source data 1). However,
UNC-86 is a notable exception as it is required for the expression of most factors (Figure 3A). Note-
worthy, SEM-4, that is downstream UNC-86, is also required for AST-1 and partially for HLH-3
expression. Thus, UNC-86 effects could be, at least in part due to SEM-4 regulation. Finally, addi-
tional more modest effects are also observed between other TF pairs, such as the regulation of AST-
1 and EGL-46 by HLH-3 (Figure 3A and summarized in Figure 3B).
Since TFs required for neuronal terminal differentiation are often also required to maintain the
correct differentiated state (Deneris and Hobert, 2014), we explored whether this was also the case
for the HSN TFs. We find that UNC-86, SEM-4, AST-1, EGL-46 and EGL-18 expression is maintained
in HSN after differentiation while HLH-3 expression is not observed after larval L4 stage (Figure 2A
and B). RNAi experiments to knock down the expression of the adult expressed TFs after HSN matu-
ration produce defects in the maintenance of tph-1 and cat-1 expression (Figure 3C). Additionally,
the use of temperature-sensitive alleles for ast-1, unc-86 and sem-4 leads to similar maintenance
defects (Figure 3—figure supplement 1). Our results revealed that these five TFs are continuously
required to maintain the correct HSN differentiated state.
Distinct cis-regulatory modules control serotonin pathway gene
expression in different subclasses of serotonergic neurons
We next performed a comprehensive, in vivo analysis of the cis-regulatory modules (CRMs) for 5HT
pathway genes to analyze how the HSN TFs regulate HSN terminal differentiation.
First, we dissected the regulatory regions of the 5HT pathway genes by in vivo reporter analysis
and isolated the minimal CRMs able to direct expression in each serotonergic neuron subclass (Fig-
ure 4 and Figure 4—figure supplement 1). We found that for each gene, different CRMs were
active in specific subclasses of serotonergic neurons (HSN, NSM or ADF). This suggests that expres-
sion of the same 5HT pathway gene is independently regulated in each of the three serotonergic
neuron subclasses. These results, together with previous reports of different TF mutants affecting
specific subclasses of serotonergic neurons (Desai et al., 1988, Olsson-Carter and Slack, 2010,
Zhang et al., 2014, Zheng et al., 2005) support the presence of subclass-specific serotonergic dif-
ferentiation programs. Of note, 5HT pathway gene CRMs in some cases partially overlap (Figure 4).
This overlap might be due to the presence of shared TFBS among serotonergic neuron subclasses
and indeed, UNC-86 regulates both NSM and HSN differentiation (Sze et al., 2002). We found that
disruption of POU TFBS in tph-1 and bas-1 HSN CRMs but not in cat-1 CRM (discussed in the follow-
ing section) affects both HSN and NSM expression. TFs are pleiotropic and it is known that the same
TF can act with different combinations of TFs in different neuronal types to control neuron-type-spe-
cific genetic programs (Hobert, 2016).
The observed serotonergic subclass independent regulation of 5HT pathway genes is in sharp
contrast with our previous study of the dopaminergic regulatory logic in which all four subclasses of
dopaminergic neurons are regulated by the same combination of TFs and through unique CRMs
(Doitsidou et al., 2013; Flames and Hobert, 2009). Dopaminergic neuron subclasses are function-
ally similar (mechanosensory neurons), which may explain why they can share a unique TF combina-
tion to select a similar transcriptome. Conversely, the functional and molecular diversity of
serotonergic neuron subclasses would require independent TF programs to select diverse terminal
transcriptomes.
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Figure 3. UNC-86 is a master regulator of the HSN transcription factor combination. (A) Expression of the HSN
TFs in different mutant backgrounds. All scorings were performed at adult stages except for HLH-3, where early L4
larvae were scored. Embryonic HLH-3 expression is unaffected in unc-86 mutants (data not shown). Graphs show
Figure 3 continued on next page
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HSN transcription factor combination acts directly on target genes
Next, to assess whether the action of the HSN TF combination was direct on the serotonergic regu-
latory regions, we focused our analyses on the HSN minimal CRMs from the three 5HT pathway
genes that showed the strongest phenotypes in our previous mutant analysis: tph-1 (TPH), cat-1
(VMAT) and bas-1 (AADC). We performed site-directed mutagenesis on predicted TFBS in these
CRMs and analyzed in vivo the effect of the mutations.
Our analysis, explained in detail below, revealed that all members of the HSN TF combination act
directly upon 5HT pathway gene CRMs. Each CRM has a different disposition of TFBS arrangements
supporting the flexible function of the HSN TFs. Additionally, we found examples of redundancy
between TFBS that provide robustness of expression to the system and whose functionality can only
be revealed in the context of smaller CRMs or mutant backgrounds. Notably, redundancy is specific
to the CRM architecture as two TFs can act redundantly in one CRM but not in others. Finally, we
also found that short HSN CRMs that lack TFBS for some HSN TF members can drive partially pene-
trant HSN expression, while longer CRMs with functional binding sites for additional members of
HSN TFs drive more robust expression. This direct but flexible action of a combination of TFs to
directly regulate cell type specification has been previously termed ‘TF collective’ mode of regula-
tion (Junion et al., 2012; Spitz and Furlong, 2012), accordingly, we termed this set of TFs the ‘HSN
TF collective’.
The HSN minimal CRM for tph-1 (TPH) (tph-1prom2, Figure 4A) contained predicted binding
sites for all six HSN TF members (Figure 5A). In vivo mutation reporter analyses revealed that all
except the SPALT- and GATA-binding sites were required for proper tph-1 expression in HSN
(Figure 5A and Figure 5—figure supplement 1). SEM-4 (SPALT) is required for ast-1 expression
thus its effect on tph-1 expression could be indirect. Paradoxically, egl-18 (GATA) mutants showed
defects in tph-1prom2 expression, similar to what was observed for the full-length reporter
(Figure 5B). Taking into account that EGL-18 does not regulate the expression of any member of
the HSN TF collective, it may act upstream of another unidentified TF to regulate tph-1prom2
expression. Alternatively, EGL-18 may be recruited to the tph-1 promoter even in the absence of
functional GATA -binding sites, perhaps through interactions with other members of the HSN TF col-
lective. Similar binding site-independent recruitment of TFs, when combinatorially binding in a TF
collective, has been reported for other combinations of TFs (Junion et al., 2012; Uhl et al., 2016).
The HSN minimal CRM for cat-1 (VMAT) (cat-1prom14, Figure 4B) also contained predicted bind-
ing sites for the HSN TF collective (Figure 5C). Point mutation analyses revealed functionality of all
but INSM-binding sites (Figure 5C and Figure 5—figure supplement 1). In agreement with this
observation, we found that cat-1prom14 expression does not require EGL-46 (INSM) factor
(Figure 5D). However, the penetrance of HSN expression for the minimal cat-1prom14 was much
lower than for the full-length reporter (55% versus 100% expression, respectively, Figure 5D). This
indicates that additional TFBS outside of the minimal CRM are required to promote robust HSN
expression. Indeed, full-length reporter (cat-1prom1) expression was affected in egl-46 mutants
(Figure 5D). These results suggest that, although partial expression from cat-1 can be achieved with-
out EGL-46, this TF is required for robust expression in the context of the full cat-1 promoter.
Figure 3 continued
the percentage of TF expression in mutant animals relative to wild type expression. n > 100 cells per condition,
Fisher’s exact test, *: p-value<0.05, See Source data 1 for raw data and exact p-values. (B) Summary of
relationships among the HSN TF combination, black arrows mean strong effect (more than 50% loss of expression)
and grey arrows depicts the rest of significant defects. (C) Loss-of-function (RNAi) experiments after HSN
differentiation show that AST-1, UNC-86, SEM-4, EGL-46 and EGL-18 are required to maintain proper tph-1::yfp
and cat-1::MDM2::gfp (unstable GFP) reporter expression. Worms were also scored prior to RNAi treatment to
confirm correct HSN differentiation before starting the experiment. n > 100 cells per condition, Fisher’s exact test,
*: p-value <0.05. See Source data 1 for raw data and Figure 3—figure supplement 1 for maintenance analysis
with temperature-sensitive alleles.
DOI: https://doi.org/10.7554/eLife.32785.008
The following figure supplement is available for figure 3:
Figure supplement 1. AST-1, UNC-86 and SEM-4 are required to maintain the HSN differentiated state.
DOI: https://doi.org/10.7554/eLife.32785.009
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The requirement for GATA sites in the cat-1 minimal CRM contrasted with the lack of an expres-
sion defect of a full-length cat-1 reporter in egl-18 (GATA) mutants (Figure 5D). However, when we
analyzed the minimal cat-1 CRM (cat-1prom14) in egl-18 mutants we found that its activity was
affected in this mutant background (Figure 5D). Thus, EGL-18 directly regulates cat-1 expression
but its loss can be compensated in the context of a large regulatory region by other unknown fac-
tors. We confirmed EGL-18 direct binding to the cat-1 promoter in vitro using electrophoretic mobil-
ity shift assays (EMSA) (Figure 5—figure supplement 2).
The HSN minimal CRM for bas-1 (AADC) (bas-1prom18, Figure 4C) contained predicted binding
sites for four TFs from the HSN TF collective: ETS, POU, GATA and SPALT TFs, but lacked any
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Figure 4. Distinct cis-regulatory modules control serotonin pathway gene expression in different subclasses of serotonergic neurons (A–D) cis-
regulatory analysis of the 5HT pathway genes. White boxes underneath each gene summarize the smallest CRM that drive expression in each
serotonergic neuron subclass. Thick black lines symbolize the genomic region placed upstream of GFP (green box) and dashed lines are used to place
each construct in the context of the locus. OA: other aminergic cells (RIC, RIM, AIM, RIH, CEPs, ADE, PDE, VC4/5) that also share the expression of
some 5HT pathway genes. Numbers in brackets represent the coordinates of each construct referred to the ATG. +: >60% GFP positive cells; +/ : 20–
60% GFP cells;  : <20% GFP cells. x/y represents the number of lines with the expression pattern (x) from the total lines analyzed (y). n > 60 cells per
line. See Figure 4—figure supplement 1 for raw values.
DOI: https://doi.org/10.7554/eLife.32785.010
The following figure supplement is available for figure 4:
Figure supplement 1. 5HT pathway gene CRM analysis.
DOI: https://doi.org/10.7554/eLife.32785.011
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Figure 5. HSN transcription factor combination acts directly on target genes. (A) tph-1 minimal HSN CRM (tph-
1prom2) mutational analysis. Black crosses represent point mutations to disrupt the corresponding TFBS. +: > 60%
of mean wild type construct values; +/ : expression values 60–20% lower than mean wild type expression values;
 : values are less than 20% of mean wild type values. n > 60 cells per line. x/y represents the number of lines with
Figure 5 continued on next page
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predicted INSM- or HLH-binding sites. Reporter analyses of the minimal CRM revealed that ETS-,
POU- and SPALT- but not GATA-binding sites were required for expression in HSN (Figure 5E and
Figure 5—figure supplement 1). Similar to cat-1, a bas-1 functional binding site for several TFs was
detectable only in the context of the minimal small CRMs while there was no defect in expression of
the full-length reporter in the corresponding TF mutant backgrounds. For example, we found func-
tional ETS- (ast-1) binding sites in bas-1prom18 while expression of the full-length bas-1 reporter
was unaffected in ast-1 (ot417) (Figure 5G). As ast-1 (ot417) is a hypomorphic allele, we confirmed
that ast-1 is not required for bas-1 full-length reporter expression by mosaic analyses with a rescuing
array in a null ast-1 allele (hd92) (87 out of 87 ast-1 null HSN neurons expressed bas-1). We analyzed
minimal CRM bas-1prom18 activity in ast-1(ot417) mutants and found a small but significant reduc-
tion in the percentage of GFP-positive HSNs (Figure 5G). We also confirmed AST-1 binding to the
bas-1 promoter in vitro using EMSA (Figure 5—figure supplement 2). Altogether, these results sug-
gest that AST-1 can bind and activate transcription from the bas-1 minimal CRM as can EGL-18 from
cat-1 minimal CRM. In both cases, however, other factors can compensate for their loss by activating
transcription from regulatory sequences outside the minimal CRMs. This genetic redundancy for
some members of the HSN TF collective at specific 5HT pathway genes possibly acts as a mechanism
to ensure that differentiation is robust.
Although HLH-3 (bHLH) and EGL-46 (INSM) were required for full-length bas-1 expression
(Figure 1E), no functional HLH- or INSM-binding sites were found in the minimal bas-1 CRM (bas-
1prom18) (Figure 5E). Similar to the minimal cat-1 CRM (cat-1prom14), GFP expression of bas-
1prom18 was partially penetrant (ranging from 38% to 83% depending on the transgenic line, Fig-
ure 5—figure supplement 1), while a longer construct (bas-1prom13) was more robustly expressed
(90% expression in all lines, Figure 5—figure supplement 1). bas-1prom13 contains bHLH- and
INSM-binding sites and INMS-binding site mutation, but not bHLH mutation, leads to expression
defects which suggest a direct role for EGL-46 in robust bas-1 expression (Figure 5F).
We did not find functional GATA-binding sites in bas-1 CRMs, and egl-18 (GATA) mutants did
not show bas-1 expression defects either. This would suggest that GATA factors are dispensable for
the regulation of this gene. However, as we had already observed genetic redundancy in other
CRMs, we considered that this could also be the case for bas-1 regulation. First, we analyzed bas-1
minimal CRM expression (bas-1prom18) in egl-18(ok290) mutants and found that EGL-18 was
Figure 5 continued
the expression pattern (x) from the total lines analyzed (y). See Figure 5—figure supplement 1 for raw values and
nature of the mutations and Figure 5—figure supplement 2 for in vitro binding. (B) tph-1prom2::gfp expression is
partially affected in egl-18(ok290) mutants. In red, significant defects relative to wild type. n > 100 cells for each
genotype. (C) cat-1 minimal HSN CRM (cat-1prom14) mutational analysis. (D) cat-1prom14::gfp expression is
unaffected in egl-46 mutants, which coincides with the lack of phenotype when INSM binding sites are mutated in
this construct. cat-1prom14::gfp contains functional GATA sites and, as expected, its expression is affected in egl-
18 mutants. Expression of a longer reporter (cat-1prom1::gfp) is independent of egl-18 revealing compensatory
effects in the context of big regulatory sequences. (E) bas-1 minimal HSN CRM (bas-1prom18) mutational analysis.
(F) A longer bas-1 construct (bas-1prom13) is more robustly expressed in HSN (90% expression compared to mean
48% expression of bas-1prom18 reporter lines). This construct contains functional INSM binding sites. (G) bas-
1prom18::gfp expression is affected in ast-1(ot417) and egl-18(ok290) mutants. Expression of a longer reporter
(bas-1::prom1) is independent of ast-1 and egl-18 revealing compensatory effects in the context of big regulatory
sequences. (H) GATA-binding site point mutation does not significantly affect bas-1::gfp expression in the
wild type background (no significant difference between mean expression of three lines of bas1prom1 and three
lines of bas1prom18). However, it synergizes with ast-1 mutant background leading to a complete loss of GFP
expression. These results unravel a direct role for GATA sites in bas-1 gene expression and synergy between egl-
18 and ast-1.
DOI: https://doi.org/10.7554/eLife.32785.012
The following figure supplements are available for figure 5:
Figure supplement 1. Primary data from the mutagenesis analysis (Figure 5).
DOI: https://doi.org/10.7554/eLife.32785.013
Figure supplement 2. UNC-86, EGL-18 and AST-1 bind to the 5HT pathway gene CRMs in electrophoretic
mobility assays.
DOI: https://doi.org/10.7554/eLife.32785.014
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required for its normal expression (Figure 5G). Next, to determine whether the role for GATA fac-
tors in bas-1 expression was direct, we analyzed the expression of a bas-1 minimal CRM carrying
GATA-binding site mutations (bas-1prom78) in the ast-1(ot417) genetic background. Interestingly,
while GATA-binding site mutations had no significant effects in wild type worms, we found a com-
plete loss of expression of this construct in ast-1(ot417) mutants (Figure 5H). These results revealed
both a direct role for GATA factors in bas-1 expression and redundancy/compensatory effects
between egl-18 and ast-1. Interestingly, these two factors do not act redundantly in other CRMs
such as tph-1.
Of note, despite the fact that HLH-3 expression is not maintained during adulthood (Figure 2B)
we find functional bHLH-binding sites both in tph-1 and in cat-1 CRMs. These results suggest that
HLH-3 is directly required to initiate expression of some HSN effector genes. Similar direct action on
effector genes has been described for mouse ortholog ASCL1 in the regulation of neuronal differen-
tiation (Raposo et al., 2015).
HSN TF collective shows enhancer-context dependent synergistic
relationships
Our cis-regulatory analysis revealed compensatory effects among the HSN TF collective, thus, to
increase our understanding of the TF collective action, we performed double mutant analysis. We
analyzed tph-1, cat-1 and bas-1 reporters because their HSN CRMs contain functionally verified
binding sites for all six factors (Figure 5). unc-86 and sem-4 null mutants show complete loss of
expression of tph-1, cat-1 and bas-1, thus we used hypomorphic alleles with partial phenotypes for
double mutant analysis.
Synergism was the most common effect in our double mutant analysis, although we also found
epistatic effects, additivity and suppression (Figure 6, Figure 6—figure supplement 1 and Fig-
ure 6—source data 1). We found synergism among different members of the HSN TF collective in
their action upon tph-1, cat-1 and bas-1 reporters (Figure 6A–H). Interestingly, the same pair of TFs
acting synergistically in the regulation of one reporter can show a different genetic relationship in
the regulation of a different gene (Figure 6E–H). For example, while unc-86 acts synergistically with
sem-4 and hlh-3 in the regulation of cat-1 expression, it shows additive effects with both TFs in the
regulation of tph-1 reporter (Figure 6E,F). Similarly, hlh-3 shows synergy with egl-18 and egl-46 in
the regulation of cat-1 and tph-1 respectively, while it is epistatic to egl-18 in the regulation of bas-1
(Figure 6G,H). Reporter specific synergistic effects have been previously described
(Doitsidou et al., 2013; Zhang et al., 2014) and are likely a direct consequence of the flexibility of
the TF collective mode of action that shows different disposition of functional binding sites in each
enhancer. Unexpectedly, hlh-3 mutation suppresses egl-46 phenotype in the regulation of cat-1
expression (Figure 6H). Genetic suppression is an intriguing phenotype that could reflect complex
effects of competition for protein-protein interactions. We found additional examples of suppression
in our double mutant analysis (Figure 6—figure supplement 1)
The HSN TF collective has pleiotropic functions. To try to avoid pleiotropic effects, we took
advantage of our cis-regulatory data to perform combinations of TFBS mutations. To check for TFBS
interactions, our analysis was limited to those sites which mutations produced only partial defects
(Figure 5). We tested three out of the four possible combined TFBS mutations; however, none of
these constructs showed synergistic effects (Figure 6—figure supplement 1). Interestingly, double
cis SPALT- and GATA- BS mutations do not show synergy in the context of the minimal tph-1 CRM
despite the synergistic effect observed for sem-4, egl-18 double mutants in the regulation of tph-1
full length reporter. As these two factors do not regulate each other’s expression (Figure 3B), it is
possible that TFBS mutations are more easily compensated than mutations in the corresponding
trans-activating factors.
As we were limited by the lack of additional BS mutations with partial effects, we next combined
cis mutations of the TFBS with trans effects of TF single mutants. Combined cis/trans mutant analysis
revealed synergistic relationships among two additional pairs of the HSN TF collective (Figure 6I).
Altogether, we found synergistic relationships among 9 out of the 15 possible HSN TF collective pair
combinations (Figure 6—figure supplement 1 and Figure 6—source data 1). In addition to syner-
gism, additivity and epistasis, we found several examples of genetic suppression both in the double
mutant and the cis/trans mutant analysis (Figure 6I and Figure 6—figure supplement 1). Similar to
the other genetic interactions, suppression is also TF pair and enhancer context specific.
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Altogether, the emerging picture is that of a joint action of the HSN TF collective upon their
direct target genes. This regulation is flexible and often partially redundant showing synergistic rela-
tionships among different members of the HSN TF collective. Importantly, specific relationships and
dependencies are determined by the CRM context and by the specific TF pairs tested.
The HSN regulatory signature allows de novo identification of HSN
expressed genes
Our results suggest that the HSN TF collective is required for broad activation of HSN effector genes
(and not only for 5HT pathway gene expression) (Figure 1) and it acts directly on the regulatory
regions of their target genes (Figure 5). Since the members of the HSN TF collective belong to six
different TF families that recognize very different binding sites (Figure 7A), we wondered whether
the clustering of binding sites for the HSN TF collective in regulatory regions of HSN effector genes
might confer sufficient specificity to impose a defining regulatory signature.
There are 96 genes known to be expressed in the HSN neuron (Supplementary file 2)
(Hobert et al., 2016), excluding pan-neuronal features which are regulated in a very redundant man-
ner (Stefanakis et al., 2015). We analyzed upstream and intronic sequences of HSN expressed
genes in search of DNA windows (up to 700 bp length) containing at least one position weight
matrix match for all six members of the HSN TF collective (termed the ‘HSN regulatory signature’)
(Figure 7A). We found that known HSN expressed genes contained large upstream and intronic
sequences, thus, for comparison purposes, we built ten thousand sets of 96 random genes with simi-
lar upstream and intronic length distribution. A significantly higher percentage of HSN expressed
genes contain the HSN regulatory signature compared to the random sets of genes (p<0.05)
(Figure 7B, Figure 7—source data 1).
Studies in Drosophila and vertebrates have shown that functional enhancers that are bound by
combinations of TFs show higher interspecific conservation compared to enhancers bound by single
TFs (Ballester et al., 2014; Khoueiry et al., 2017; Stefflova et al., 2013). Thus, we performed a
similar motif search in C. brenneri, C. remanei, C. briggsae and C. japonica genomes and calculated,
for each C. elegans gene, the proportion of its orthologs that had, in its upstream or intronic
sequence, at least one 700 bp window with binding sites for all the six TFs. We considered the HSN
regulatory signature as phylogenetically conserved when orthologous genes in all species displayed
the signature within their upstream or intronic regions. We found that the inclusion of the conserva-
tion criteria in this analysis slightly increased the difference between HSN and the random sets of
genes (p<0.01) (Figure 7B).
The higher prevalence of conserved signature in HSN expressed genes supports the idea that the
HSN TF collective broadly selects the HSN transcriptome. We tested HSN regulatory signature win-
dows from four of the known HSN expressed genes by in vivo reporter assays and confirmed that
they correspond to active HSN enhancers (three out of four tested contructs show HSN expression,
Figure 7—figure supplement 1 and Figure 7—source data 2). Of note, C. elegans functional HSN
regulatory signature windows do not show a high level of sequence conservation (Figure 7—figure
supplement 1), which is in agreement with rapid evolution of regulatory sequences (Villar et al.,
2015).
Next, we examined the distribution of the HSN regulatory signature windows across the entire C.
elegans genome. Remarkably, we found that it was preferentially found in the putative regulatory
Figure 6 continued
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DOI: https://doi.org/10.7554/eLife.32785.017
Figure supplement 1. HSN TF collective genetic interactions.
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sequences of genes known to be expressed in neurons or that have a neuronal function compared
to the rest of the genome, as would be expected for genes controlled by the HSN TF collective
(Figure 7C). Filtering of conserved regulatory signatures further increased the difference between
‘neuronal’ and ‘non-neuronal’ genomes, which adds support to its functionality (Figure 7C). Gene
ontology analysis of all genes in the C. elegans genome with HSN regulatory signature revealed
enrichment of processes controlling transcription, axon guidance, synaptic transmission and oviposi-
tion, all characteristic of HSN differentiation and function (Figure 7D).
Our experimental data (Figure 5), in agreement to the TF collective model (Spitz and Furlong,
2012), shows that the presence of TFBS for all TF collective members is not required in specific
enhancer contexts. Thus, we aimed to analyze if HSN regulatory windows lacking TF-binding sites
for one or two TF classes show also an enriched distribution in HSN expressed genes and in the neu-
ronal genome. We find that, in contrast to the six-motif HSN regulatory signature, windows contain-
ing only five or four types of HSN TF motifs are not preferentially found in HSN expressed genes
compared to the 10.000 random sets of genes with or without filtering for conservation (p>0.05 in
all conditions) (Figure 7—figure supplement 2). Additionally, genomic distribution of the HSN regu-
latory signature is less enriched in neuronal genes compared to non-neuronal genes when including
windows lacking one or two HSN TF collective motifs (Figure 7—figure supplement 2). Moreover,
while only 25% of the genes (4,968) contain at least one assigned six-motif regulatory window, regu-
latory windows with five or more motifs are found in 52% of the genes (10,415) and 72% of the
genes (14,325) contain windows with four or more motifs. Finally, GO comparative analysis shows
that genes with assigned 6-motif HSN regulatory windows show the highest enrichment in terms
related to HSN function and that the additional GO terms obtained when including windows lacking
either one or two HSN TF motifs are not related to neuronal functions (Figure 7—figure supple-
ment 2). Altogether, our data shows that the most prevalent mark of HSN expressed genes is the
regulatory signature with all six TFBS. Even if some HSN enhancers can still be functional with a par-
tial complement of HSN TF collective binding sites, at the genomic level, including enhancers with
missing TFBS abolishes cell type specificity.
Next, we aimed to identify new genes expressed in HSN based solely on the presence of the
HSN regulatory signature. To this end, we randomly selected 35 neuronal genes with a conserved
HSN regulatory signature and generated transgenic reporter lines. We found that 13 out of the 35
constructs (37%) showed GFP expression in HSN (Figure 7E and Figure 7—source data 2), while
none of 10 randomly picked similar-sized intergenic regions of neuronal genes lacking the HSN regu-
latory signature led to reporter expression in HSN (Figure 7—source data 2). Importantly, all
reporter constructs, including the negative controls, did drive GFP expression in a variable set of
additional neurons, which might be due to the compact nature of the C. elegans genome.
Figure 7 continued
regulatory signature. (E) Four representative examples of de novo identified HSN active enhancers. Black lines represent the coordinates covered by
bioinformatically predicted HSN regulatory signature windows (indicated by ‘w’ and a number). Green lines mark the region used in our analysis. Dark
blue bar profiles represent sequence conservation in C. briggsae, C. brenneri, C. remanei and C. japonica. n > 60 cells per line. See Figure 7—source
data 1 for a list of all reporters and raw scoring data. Expression level of most of these reporters is regulated by unc-86 (Figure 7—figure supplement
3).
DOI: https://doi.org/10.7554/eLife.32785.018
The following source data and figure supplements are available for figure 7:
Source data 1. Scripts for HSN regulatory signature analysis.
DOI: https://doi.org/10.7554/eLife.32785.022
Source data 2. Raw scoring data of de novo finding of HSN enhancers and dependency on unc-86 function.
DOI: https://doi.org/10.7554/eLife.32785.023
Figure supplement 1. HSN regulatory signature distribution in HSN expressed genes.
DOI: https://doi.org/10.7554/eLife.32785.019
Figure supplement 2. Analysis of the HSN regulatory signature including windows missing one or two TFBS motifs.
DOI: https://doi.org/10.7554/eLife.32785.020
Figure supplement 3. Expression of identified HSN regulatory windows depends on unc-86.
DOI: https://doi.org/10.7554/eLife.32785.021
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Finally, to analyze if the activity of the identified HSN regulatory windows was under the control
of the HSN TF collective we crossed them into the unc-86(n846) mutant. The expression of 12 out of
15 reporter constructs (80%) was significantly reduced in unc-86 mutants (Figure 7—figure supple-
ment 3). Of note, onset of expression of the HSN regulatory window reporters can be used to pre-
dict the effect of unc-86 mutation: while all reporters with L4 onset of expression are strongly
dependent on unc-86, HSN regulatory windows that initiate expression at earlier stages show more
modest dependency on unc-86 function (Figure 7—figure supplement 3).
Our results reveal that the presence of a conserved HSN regulatory signature can be successfully
used to de novo identify HSN expressed genes. However, our high level of false positives (63%) indi-
cates that the signature itself is not sufficient to induce HSN expression. Additional TFs might be
part of the HSN TF collective and thus active HSN regulatory signature windows would contain addi-
tional TFBS. Repressive elements or chromatin accessibility could also block HSN expression of non-
functional HSN regulatory signature windows, indeed members of the SWI/SNF chromatin remodel-
ing complex are required for correct HSN terminal differentiation (Weinberg et al., 2013). It is also
possible that specific syntactic rules (TFBS order, distance and disposition) discriminate functional
from non-functional HSN regulatory signature windows. Future studies will help identify additional
players and rules for HSN terminal differentiation.
Deep homology between HSN and mouse raphe serotonergic neurons
Mouse orthologs for four out of the six TFs of the HSN TF collective are involved in mammalian sero-
tonergic specification: ASCL1 (bHLH TF ortholog of HLH-3) (Pattyn et al., 2004), GATA2/3 (GATA
TF ortholog of EGL-18) (Haugas et al., 2016), INSM1 (Zn Finger Insm TF ortholog of EGL-46)
(Jacob et al., 2009) and PET1 (ETS TF ortholog of AST-1) (Hendricks et al., 2003). Additionally,
BRN2 (also known as POU3F2, a POU TF from the same family that UNC-86) has been associated
with serotonergic specification, although its expression in serotonergic neurons has not been studied
(Nasu et al., 2014). We analyzed BRN2 expression in serotonergic differentiating neurons and found
it expressed in serotonergic progenitors and serotonergic newborn neurons at embryonic stage
E11.5, when serotonergic neurons are differentiating (Figure 8A and B). Finally, SALL2 is the closest
mouse ortholog for C. elegans SEM-4, but there is no known role for any SALL TFs in serotonergic
specification. We found that SALL2 is also expressed in serotonergic progenitors and serotonergic
newborn neurons at embryonic stage E11.5 (Figure 8A and C).
In evolutionary biology, the term deep homology refers to the relationship between two struc-
tures that share the genetic mechanisms governing their differentiation (Shubin et al., 1997). As C.
elegans HSN and mouse raphe serotonergic neurons share many of the TFs required for their differ-
entiation, we hypothesized that they might be homologous structures. If this were the case, then
HSN neurons and mouse serotonergic raphe should not merely share the expression of 5HT pathway
genes, which are also present in the other C. elegans serotonergic neuron classes, but also be more
broadly similar in molecular terms.
To address this, we used available gene expression data from the WormBase to generate partial
expression profiles for the 118 neuronal classes of the C. elegans hermaphrodite. This partial expres-
sion profile can be successfully used to reproduce the anatomical classification of C. elegans neuron
subtypes (Hobert et al., 2016). We assigned mouse orthologs to C. elegans neuronal genes and
merged the resulting table with another one featuring the available mouse raphe serotonergic neu-
ron transcriptome (Okaty et al., 2015). Hierarchical clustering of this data set shows that HSN is,
molecularly, the closest neuron to the mouse raphe neurons (Figure 8D). Importantly, hierarchical
clustering generated from mouse orthologs of C. elegans genes resembles the neuron class cluster-
ing generated directly from C. elegans genes (Hobert et al., 2016). HSN and mouse raphe close
relationship is not merely due to 5HT pathway genes expression because NSM and ADF serotoner-
gic neurons are molecularly more distant to the mouse raphe serotonergic neurons than HSN
(Figure 8D and Source Data 5). Moreover, HSN remained the most similar neuron to mouse seroto-
nergic raphe neurons even after removing the 5HT pathway genes from the HSN expression profile
(Figure 8—figure supplement 1). Shared orthologous genes between HSN and mouse raphe sero-
tonergic neurons belong to different functional categories including axon guidance and migration,
neurotransmission, or transcriptional regulation (Table 1). Importantly, HSN proximity to mouse
serotonergic neurons was not maintained with other mouse neuronal populations (Figure 8—figure
supplement 1).
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Finally, to test if there is deep homology between HSN and mouse raphe
serotonergic neurons, we tested if mouse orthologs of the HSN TF collective can functionally substi-
tute for their worm counterparts. We performed cell-specific rescue experiments of C. elegans
mutants and found that mouse Pet1, Ascl1, Insm1, Gata2 and Sall2 could respectively substitute ast-
1, hlh-3, egl-46, egl-18 and sem-4, which suggest that this regulatory program could be phylogeneti-
cally conserved (Figure 8E and F). Of note, our rescue experiments, both with C. elegans or mouse
genes, restore tph-1 expression but do not rescue egg-laying defects. The HSN TF collective has
pleiotropic actions in other tissues that also contribute to the egg laying phenotype (Basson and
Horvitz, 1996; Doonan et al., 2008; Eisenmann and Kim, 2000; Koh et al., 2002) what could
explain the persistence of egg-laying defects in the HSN specific rescue experiments.
In sum, these results revealed an unexpected level of regulatory and molecular proximity between
C. elegans HSN and mouse serotonergic raphe neurons suggesting that deep homology might exist
between these two neuronal types.
Discussion
Our extensive analysis of the HSN regulatory logic has revealed insights into how the complement of
cell-type-specific enhancers is selected. We found that numerous TFs (here we identify six but likely
additional TFs are required) act in conjunction to directly activate the HSN regulatory landscape.
HSN TF collective acts through the HSN regulatory signature, which is found preferentially associ-
ated to genes of the neuronal genome that are related to HSN function.
Regulation of C. elegans neuron specification is unexpectedly complex
Neuronal terminal differentiation programs have been best characterized in C. elegans. So far, rela-
tively simple TF combinations, composed of two or three members, were shown to be required, and
in some contexts sufficient, to select specific neuronal types. These TFs have been termed Terminal
Selectors (Doitsidou et al., 2013; Serrano-Saiz et al., 2013; Van Buskirk and Sternberg, 2010;
Zhang et al., 2002). In some cases, additional TFs act together with Terminal Selectors to partially
modulate the transcriptomes of specific neuronal subclasses (Kerk et al., 2017; Kratsios et al.,
2017). Accordingly, it has been suggested that, in C. elegans, a rather simple organization of CRMs
control the expression of neuronal terminal features (Holmberg and Perlmann, 2012). Our results,
however, demonstrate a more complex scenario in the regulation of the HSN transcriptome. We
have identified six TFs required for HSN terminal differentiation acting directly upon the regulatory
regions of HSN expressed genes. Nonetheless, additional unidentified factors are likely to compose
the HSN TF collective. We found that the HSN TF collective includes a proneural TF (hlh-3) that is
required to initiate HSN differentiation but whose expression, like all proneural factors
(Guillemot and Hassan, 2017), is not maintained in the mature neuron. Future experiments should
determine if, as has been proven for its mouse ortholog Ascl1 (Wapinski et al., 2013), hlh-3 acts as
Figure 8 continued
double labeled cells. Scale bar: 20 mm. (D) Hierarchical clustering analysis of C. elegans neuron expression profiles with mouse serotonergic raphe
neurons shows that HSN (in green) is closest to mouse serotonergic neurons (in blue). Other C. elegans serotonergic neuron classes (ADF and NSM in
red) do not show a close relationship with mouse serotonergic raphe. R1D: Dorsal serotonergic neurons from rhombomere r1; R1M: Medial
serotonergic neurons from rhombomere r1; R2: serotonergic neurons from rhombomere r2; R3: serotonergic neurons from rhombomere r3; R5:
serotonergic neurons from rhombomere r5; R6: serotonergic neurons from rhombomere r6. See also Figure 8—figure supplement 1. (E) Micrographs
showing tph-1::gfp expression in wild type animals, ast-1(ot417) mutants, and ast-1(ot417) mutants rescued with ast-1 cDNA or mouse Pet1 cDNA
expressed under the bas-1 promoter whose expression in not affected in this mutant background. (F) Quantification of tph-1::gfp HSN expression
rescue of different HSN TF collective mutants with worm and mouse ortholog cDNAs. n > 100 cells per condition. Fisher’s exact test, *: p-value<0.05.
‘L’ indicates the transgenic line number.
DOI: https://doi.org/10.7554/eLife.32785.024
The following source data and figure supplement are available for figure 8:
Source data 1. Scripts for C.elegans and mouse neuron comparison.
DOI: https://doi.org/10.7554/eLife.32785.026
Figure supplement 1. HSN neuron is the C. elegans neuron molecularly closest to mouse raphe serotonergic neurons.
DOI: https://doi.org/10.7554/eLife.32785.025
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Table 1. C. elegans HSN and mouse raphe serotonergic neuron homology
C. elegans gene name Description Mammalian gene name
Serotonergic biosynthetic pathway
bas-1 a Dopamine decarboxylase Ddc
cat-1a Vesicular monoamine transporter Slc18a2
cat-4 GTP cyclohydrolase 1 Gch1
tph-1 a Tryptophan hydroxylase Tph2
Axon guidance and Migration
ebax-1 a Elongin-B/C E3 ligase Zswim5/6/8
egl-43 a PR domain containing Prdm16
fmi-1 Flamingo homolog Celsr2/3, Fat1/3, Dchs1
madd-2 a Trim protein Trim9/36/46, Fsd1/1 l, Mid2
mau-2 a Chromatid cohesion factor Mau2
mig-10 a Protein with an RA-like, PH domains and proline-rich motif Raph1, Grb10
nck-1 SH2/SH3 domain-containing protein Nck1
rig-6 a neuronal IgCAM Cntn1, 2, 3, 4, 5, 6
tbb-4 a Tubulin Tubb2a/2b/4a/4b/5
unc-40 a Netrin receptor Dcc, Neo1
unc-51 a Serine/threonine protein kinase Ulk1/2
unc-53 a Neuron navigator Nav1/2/3
Neurotransmission/Synaptogenesis
abts-1 a Anion/Bicarbonate Transporter family Slc4a7/8/10
clh-3 Voltage sensitive cloride channel Clcn2
eat-16 Regulator of G protein signaling Rgs11/19
gar-2 a G-protein-coupled acetylcholine receptor Hrh3
ggr-2 a GABA/Glycine Receptor Glra1/2, Glrb
glr-5 a Glu Receptor Grid1/2, Grik1
gsa-1 a G protein, Subunit Alpha Gnal, Gnas
ida-1 a Protein tyrosine phosphatase-like receptor Ptprn, Ptpm2
irk-1 a Inward Rectifying K (potassium) channel family Kcnj3/5/6/9/11/16/
kcc-2 a K/Cl cotransporter Slc12a5/6
mpz-1 a Multiple PDZ domain protein Mpdz, Pdzd2, Inadl, Lnx1
nhx-5 Na/H exchanger Slc9a6/7/9
nid-1 a Nidogen (basement membrane protein) Lrp1/1b
nra-4 Nicotinic Receptor Associated Nomo1
rsy-1 Regulator of synapse formation Pnisr
syg-1 a Ig transmembrane protein Kirrel, Kirrel3
nlg-1 a Neuroligin family Nlg1/2/3
unc-2 a Calcium channel alpha subunit Cacna1a/1b/1e
unc-77 Voltage-insensitive cation leak channel Nalcn
unc-103 a K + channel Kcnh2/7
Transcriptional regulation
ceh-20 a PBX TF Pbx1/2/3
egl-44 a TEA domain TF Tead1
gei-8 Nuclear receptor co-repressor Ncor1
hlh-3 a bHLH TF Ascl1
Table 1 continued on next page
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a pioneer factor for HSN terminal differentiation. In light of our findings, nematode neuronal termi-
nal differentiation programs are not necessarily simpler than those found in vertebrates, as previ-
ously proposed (Holmberg and Perlmann, 2012).
Considering the technical advantages of C. elegans as a simple model system, our work is an
example on how its study may help to identify rules of terminal differentiation in eumetazoa. The
combination of our extensive cis-regulatory analysis and the double mutant characterization allowed
us to describe the flexible action of the HSN TF collective that can activate enhancers with very dif-
ferent dispositions of TFBS. This flexibility is also made evident by the specific synergistic relation-
ships in the regulation of some enhancers and not others. We propose that these redundant actions,
globally considered, confer robustness of expression to the system.
The HSN regulatory signature identifies HSN expressed genes
Co-binding of specific combinations of TFs to the same genomic region, assessed by ChIP-seq, has
been successfully used to identify, de novo, cell-type-specific enhancers in Drosophila embryos
(Busser et al., 2015; Junion et al., 2012; Zinzen et al., 2009). However, this approach fails to
address why specific genomic regions work as enhancers. Recently, massively parallel reporter assays
(MPRA) have been used to identify generic rules of enhancer function. The analysis of synthetic
enhancers revealed that highest levels of expression are achieved with clusters of binding sites for
Table 1 continued
C. elegans gene name Description Mammalian gene name
ife-4 a Initiation factor 4E Eif4e2
sem-4 a Spalt TF Sall2,Zfp236/Znf236
Morphogenetic pathways
dsh-1 a Homolog of disheveled Dvl1/3
plr-1 a Ring finger protein Rnf215
prkl-1 a Drosophila Prickle homolog Prickle1/2
sel-10 a Suppressor/Enhancer of Lin-12(Notch) Fbxw7
Others
aak-2 a AMP-activated protein kinases Prkaa1/2
ags-3 G protein singalling modulator Gpsm1
aho-3 a Hydrolase Abhd17a/17b
ari-1 Ubiquitin-protein transferase Arih1
arr-1 G protein singaling adaptor Arrb1/2
arrd-17 a Arrestin domain protein Arrdc3
baz-2 Bromodomain adjacent to zinc finger domain Baz2a/2b
elpc-1 Elongator complex protein component Ikbkap
elpc-3 Elongator complex protein component Elp3
goa-1 a G protein,O, Alpha subunit Gnao1
kin-20 Protein kinase Csnk1d/1e
puf-9 Pumilio/FBF domain-containing Pum1/2
pxf-1 a Rap guanine nucleotide exchange factor Rapgef2/6
rep-1 Rab escort protein Chm, Chml
ten-1 a Type II transmembrane EGF-like repeats Tenm1/3/4
top-1 a
a : gene with assigned HSN regulatory signature
Topoisomerase Top1/1mt
DOI: https://doi.org/10.7554/eLife.32785.027
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different TFs (Smith et al., 2013). Another MPRA study has analyzed enhancer activity of regions
bound by the adipocyte terminal selector PPARg and has determined that the best predictor for
enhancer functionality is the presence of nearby TFBS for more than 30 different TFs expressed in
adipocytes (Grossman et al., 2017). In accordance to this complex scenario of combinatorial action
of multiple TFs in the global selection of cell type regulatory landscapes, we found that clusters of
bioinformatically predicted TFBS for the HSN TF collective can be used for the de novo identification
of HSN enhancers. Of note, our analysis still shows a high rate of false positives, which suggests that
additional features are present in HSN functional enhancers. Future analyses based on more com-
plex paradigms should facilitate the identification of such features that could include additional
TFBS (or the absence of repressor sites) or specific syntactic rules.
Deep homology, molecular homology and functional homology
between C. elegans HSN and mouse serotonergic neurons
The diversity of C. elegans serotonergic neuronal classes (NSM, ADF and HSN) contrasts with that of
tetrapod vertebrates, in which serotonergic neurons are limited to the raphe system (Flames and
Hobert, 2011). Other chordates contain additional serotonergic populations (Flames and Hobert,
2011) and serotonergic subclass diversity is also prevalent in other phyla such as arthropoda and
mollusca (Flames and Hobert, 2011), which suggests a loss of serotonergic diversity in the tetrapod
branch. As in nematodes, serotonergic subclass specification in other organisms is likely to be inde-
pendently regulated. For instance, in Drosophila, the TFs islet, hunchback and engrailed are required
for serotonergic specification of the ventral ganglion, while are dispensable for fly brain serotonergic
specification (Lundell et al., 1996; Thor and Thomas, 1997). Similarly, in zebrafish, Pet1 regulates
raphe serotonergic specification but is dispensable for the specification of other serotonergic sub-
classes (Lillesaar et al., 2007).
Considering the homologous regulatory network between HSN and mouse raphe and their
molecular proximity, our results suggest that the C. elegans HSN serotonergic neuron, but not the
NSM or ADF, could share deep homology with mouse raphe neurons. It would be interesting to
explore if NSM or ADF regulatory programs show homology to any of the programs controlling the
non-raphe serotonergic populations present in other organisms. Noteworthy, despite the homology
in TFs regulating HSN and raphe specification, both systems also show discrepancies. For example,
while the LIM TF Lmx1b is known to be a key player in mouse serotonergic differentiation
(Ding et al., 2003), we failed to identify a similar role for any C. elegans LIM TF (A.JM and N.F
unpublished). Similarly, while C. elegans GATA factor egl-18 has very redundant effects on HSN dif-
ferentiation, GATA2/3 factors are fundamental in mouse serotonergic differentiation (Haugas et al.,
2016). Considering the evolutionary distance between mammals and nematodes, the complexity of
the regulatory network (composed in C. elegans at least by six and most likely more factors) and the
fast evolutionary rate of regulatory regions, it is conceivable that the ancestral common serotonergic
regulatory network has significantly diverged between these two animal groups. We propose that
this deep homology might be the result of a common ancestor cell type, although, as we do not
have enough information about the serotonergic regulatory programs in other animal groups, an
alternative scenario is that they might have arisen independently in nematodes and vertebrates and
thus although some components would have been convergently employed others could be species
specific.
If HSN and mouse raphe serotonergic neurons were homologous cell types, we would predict
that they are also functionally homologous. Serotonergic systems in all animal groups function as
facilitators of motor output, with 5HT promoting a switch between states (Gillette, 2006). Interest-
ingly, C. elegans 5HT signaling in HSN neurons also facilitates motor output. Egg-laying behavior
transitions from inactive to active states of egg laying, and 5HT signaling in HSN mediates the onset
of the active phase (Waggoner et al., 1998). Thus, HSN and mouse serotonergic neurons would
share deep homology, as well as molecular and functional homology.
Deep homology of specific nervous system structures has been previously proposed. Conserved
TF expression patterns in annelid antero-posterior nervous system axis, including the serotonergic
progenitor region, was used to propose the existence of a common Bilaterian ancestor with central-
ized nervous system (Denes et al., 2007; Tomer et al., 2010). Additionally, homologous TF expres-
sion patterns have also been used to propose the presence of a visceral nervous system in the
common Bilaterian ancestor (Nomaksteinsky et al., 2013). Altogether, these results suggest that,
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despite considerable divergence in neuronal architecture and connectivity, deep homology could
underlie the specification of diverse neuron subtypes. The identification of homologous regulatory
programs could help identify homologous neuronal types in distant species.
Materials and methods
Key resources table
Reagent type (species) or resource Designation Source or reference Identifiers
Strain, strain
background (Caenorhabditis elegans)
C. elegans: Strain N2 Caenorhabditis Genetics
Center
WormBase: N2
Strain, strain
background (Caenorhabditis elegans)
Strain names and genotypes Supplementary file 3
Strain, strain
background (Mus musculus)
Mouse: C57Bl/6JRccHsd strain ENVIGO, Harlan. (Huntingdon, Cambridgeshire, UK) C57Bl/6JRccHsd
Strain, strain
background (Escherichia coli)
Strain OP50 Caenorhabditis Genetics
Center
OP50
Strain, strain
background (Escherichia coli)
Rosetta 2(DE3) Singles
Competent Cells: BL21 derivatives
Novagen, Merck Group. (Darmstadt, Germany) Cat#71400
Strain, strain
background (Escherichia coli)
Strain: HT115(DE3) Caenorhabditis Genetics
Center
HT115
Cell line (human) Human: HEK293T Laboratory of Oliver Hobert ATCC: CRL-3216
Transfected
construct (C.elegans)
Plasmid: pCDNA3-egl-18 This paper N/A
Antibody Mouse anti-GFP IgG1K Sigma Aldrich, Merck Group. (Darmstadt, Germany) Cat#11814460001
Antibody Anti-6X His tag
antibody [HIS.H8]
Abcam (Cambridge, UK) Cat#ab18184
Antibody Rabbit anti-5HT Sigma Aldrich S5545
Antibody Goat anti-5HT Abcam Ab66047
Antibody Rabbit anti-Sall2 Sigma Aldrich sc-6029
Antibody Alexa 555-conjugated
donkey anti-rabbit
Molecular Probes, Invitrogen (Eugene, OR) A-31572
Antibody Alexa 555-conjugated
donkey anti-goat
Molecular Probes A-21432
Antibody Alexa 488-conjugated
donkey anti-rabbit
Molecular Probes A-21206
Antibody Alexa 488-conjugated
donkey anti-goat
Molecular Probes A-11055
Recombinant DNA
reagent
Plasmid: pPD95.75 Dr Oliver Hobert Laboratory Addgene Plasmid #1494
Recombinant DNA
reagent
Plasmid: pRF4
(rol-6 (su1006))
(Mello et al., 1991) N/A
Recombinant DNA
reagent
Plasmid: ttx-3prom::mcherry (Bertrand and Hobert, 2009) N/A
Recombinant DNA
reagent
Plasmid: pBluescript Dr Oliver Hobert Laboratory N/A
Recombinant DNA
reagent
Plasmid pJJR82 Dr Mike Boxem Laboratory Addgene #75027
Recombinant DNA
reagent
Plasmid pDD162 Dr Mike Boxem Laboratory Addgene #4754
Recombinant DNA
reagent
Plasmid pDD268 (Dickinson et al., 2015) N/A
Recombinant DNA
reagent
Plasmid pJW1219 (Ward, 2015) Addgene # #61250
Continued on next page
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Continued
Reagent type (species) or resource Designation Source or reference Identifiers
Recombinant DNA
reagent
Plasmid pCFJ90 Dr Mike Boxem Laboratory Addgene #19328
Recombinant DNA
reagent
Plasmid pPD129.36 (L4440) Dr Andrew Fire Laboratory Addgene #1654
Recombinant DNA
reagent
Plasmid: pET-21b-ast-1 This paper N/A
Recombinant DNA
reagent
Plasmid: pET-21b-unc-86 (Zhang et al., 2014) N/A
Recombinant DNA
reagent
Plasmid: HSNearlyprom::ast-1 This paper N/A
Recombinant DNA
reagent
Plasmid: HSNearlyprom::hlh-3 This paper N/A
Recombinant DNA
reagent
Plasmid:
HSNearlyprom::ast-1,
HSNearlyprom::hlh-3
This paper N/A
Recombinant DNA
reagent
Plasmid: bas-1prom::ast-1 This paper N/A
Recombinant DNA
reagent
Plasmid: bas-1prom::Pet1 This paper N/A
Recombinant DNA reagent Plasmid: cat-4prom::hlh-3 This paper N/A
Recombinant DNA
reagent
Plasmid: cat-4prom::Ascl-1 This paper N/A
Recombinant DNA
reagent
Plasmid: cat-4prom::egl-46 This paper N/A
Recombinant DNA
reagent
Plasmid: cat-4prom::Insm1 This paper N/A
Recombinant DNA
reagent
Plasmid: cat-4prom::Gata2 This paper N/A
Recombinant DNA
reagent
Plasmid: kal-1prom::Sall2 This paper N/A
Sequence-based
reagent
oligonucleotides Supplementary file 4
Commercial assay
or kit
HisTrap HP Column GE Healthcare Life
Sciences (Marlborough, MA)
Cat#17-5248-01
Commercial assay
or kit
QuikChange XL Site-
Directed Mutagenesis Kit
Agilent (Santa Clara, CA) Cat# 200516
Chemical compound,
drug
EasyTides Adenosine
5’-triphosphate (ATP [g 32P])
Perkin Elmer (Waltham, MA) Cat#NEG502A250UC
Chemical compound,
drug
Power Broth Medium Molecular Dimensions (Maumee, OA) Cat#MD12-106-1
Chemical compound,
drug
Lipofectamine 2000 Invitrogen (Carlsbad, CA) Cat#11668027
Chemical compound,
drug
Isopropyl-b-D-thiogalacto
pyranoside (IPTG)
Acros Organics, ThermoFisher Scientific (Waltman, MA) Cat#BP1755-100
Chemical compound,
drug
Collagenase type IV Sigma Aldrich C-5138
Chemical compound,
drug
FluorSaveReagent Merck Millipore (Darmstadt, Germany) 345789–20 ML
Software, algorithm Gorilla (Eden et al., 2009) http://cbl-gorilla.cs.technion.ac.
Software, algorithm R (Team, 2016) https://www.r-project.org/
Software, algorithm Bioconductor (Huber et al., 2015) https://www.bioconductor.org/
Software, algorithm pvclust (R package) (Suzuki and Shimodaira, 2006) www.sigmath.es.osaka-u.ac.jp/
shimo-lab/prog/pvclust
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C. elegans strains and genetics
C. elegans culture and genetics were performed as described (Brenner, 1974). Strains used in this
study are listed in Supplementary file 3.
Mouse samples
Animals of C57Bl/6JRccHsd genetic background were housed in an animal care facility with a 12 hr
dark/light cycle and had free access to food and water. All experiments were performed according
to the animal care guidelines of the European Community Council (86 / 609 / EEC) and to Spanish
regulations (RD1201 / 2005), following protocols approved by the ethics committees of the Consejo
Superior Investigaciones Cientı´ficas (CSIC).
Generation of C. elegans transgenic lines
Gene constructs for cis-regulatory analyses were generated by cloning into the pPD95.75 vector. For
the identification of the putative binding sites the following consensus sequences were used: ETS:
CGGAWR (Wyler et al., 2016), GATA: GATA (Merika and Orkin, 1993); HLH: CAGAA/ACGTG
MatInspector Software (Cartharius et al., 2005); INSM: KNNWGSGG (Breslin et al., 2002); SPALT:
TTGTST (Toker AS 2003) and MatInspector Software (Cartharius et al., 2005); POU: WTKCAT
(Weirauch et al., 2014) and (Sze et al., 2002). Mutagenesis was performed by Quickchange II XL
site-directed mutagenesis kit (Stratagene, Santa Clara, CA). Reporters for HSN regulatory signature
analysis were generated by fusion PCR (Hobert, 2002). Generated strains and primers are listed in
the Supplementary file 3 and 4. For hlh-3 mutant rescue experiments, the entire coding sequence
of hlh-3 was cloned in front of the heat shock inducible promoter (hsp16-2). The transgenic DNA mix
was composed by hlh-3 cDNA (50 ng/ml), together with the co-injection markers rol-6(su1006) (50
ng/ml) and ttx-3::mCherry (50 ng/ml). For HSN precocious maturation experiments, cDNAs of ast-1
and hlh-3 were amplified by PCR and cloned in front of an HSN-specific promoter that drives early
expression in the HSN (see promoter sequence below) and the transgenic DNA mix concentrations
were the same as above. When both cDNAs were co-injected, we used 25 ng/ml for co-injection
markers. For rescue experiments, cDNAs corresponding to the entire coding sequence of ast-1, hlh-
3, egl-46, Pet1, Ascl1, Insm1, Sall2 and Gata2 were amplified by PCR and cloned in front of cell-spe-
cific promoters: bas-1prom, cat-4prom and kal-1prom (primers in Supplementary file 4). The trans-
genic DNA mix was composed by the DNA of interest [ast-1 (50 ng/ml in HSN early maturation
experiments and 5 ng/ml in HSN rescue experiments), hlh-3 (50 ng/ml), egl-46 (50 ng/ml), Pet1 (10 ng/
ml), Ascl1 (50 ng/ml), Insm1 (50 ng/ml), Gata2(50 ng/ul) and Sall2 (20 ng/ml)], the co-injection markers
rol-6(su1006) (50 ng/ml) and ttx-3::mCherry (50 ng/ml) and, when necessary, pBlueScript as carrier
DNA. DNA was injected into N2 animals and then crossed with their respective mutant strains. ast-1
and hlh-3 reporter strains were generated using CRISPR/Cas9-mediated fluorescent protein knock-
in, as described in (Dickinson et al., 2013; Dickinson et al., 2015). For homology arm recombina-
tion, we used plasmids containing a self-excising selection cassette: the GFP-containing pJJR82 plas-
mid (Addgene, Cambridge, MA) in the case of ast-1, and the mNeonGreen-containing pDD268
plasmid (Dickinson et al., 2015) in the case of hlh-3. To target Cas9 to the specific genomic locus,
we used the single guide RNA sequence GGGGTGACTATCGATAAAGA for ast-1, and GCTATGA
TGATCACCAGAAG for hlh-3, cloned in the pDD162 (Addgene) and the pJW1219 (Addgene) plas-
mids respectively. Injection mixes consisted on the Cas9–sgRNA plasmid (50 ng/ml for ast-1 and 100
ng/ml for hlh-3), the repair template (10 ng/ml for ast-1 and 20 ng/ml for hlh-3), and a pharyngeal co-
injection marker [2.5 ng/ml pCFJ90 (Pmyo-2::mCherry); Addgene].
Scoring
Scoring and images were performed using 60X objective in a Zeiss Axioplan2 microscope. Lack of
GFP signaling was considered OFF phenotype. As we observed no appreciable bias in reporter
expression between left and right HSN neurons, percentages were calculated regardless of side. cis-
regulatory reporter and mutant scoring was performed using young adult worms maintained at
25˚C, unless indicated. For cis-regulatory analysis a minimum of 30 animals (60 HSN cells) per line
were scored. For mutant analysis at least 100 HSN cells, roughly corresponding to 50 animals, were
scored for each genotype. For double mutant analysis, we scored young adult worms and we
included an extra phenotype category termed ‘dim’ whenever fluorescence was obviously reduced
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but still detectable. For HSN regulatory signature analysis, the three lines showing strongest GFP
under the dissecting scope were selected for scoring under the microscope. To prepare figures for
publication, images were cropped and rotated, brightness and contrast were adjusted, and maxi-
mum intensity projections (where applicable) were performed using FIJI. No other image manipula-
tions were performed.
For wild type TF expression analysis at HSN birth, an unc-86 fosmid reporter was crossed with the
desired TF reporter in order to construct double reporter strains, when possible. UNC-86 is
expressed in the HSN after cell cycle exit, approximately 400 min after fertilization and coinciding
with embryonic comma stage, which was chosen as analytical time point (Desai et al., 1988;
Finney and Ruvkun, 1990). In the particular case of hlh-3, 1 to 2 cell-stage embryos with the endog-
enous gene tagged were selected and mounted [0 hr post-fertilization (hpf) to 0.8 hpf, respectively],
incubated at 25˚C and analyzed at different time points. We determined that HLH-3 is initially
expressed in the HSN/PHB precursor cell (approximately five hpf) and maintained in the postmitotic
HSN. HSN cells were identified relative to nearby landmark cell deaths (Sulston et al., 1983). The
rest of developmental stages of the worm were identified by standard anatomical features. For hlh-3
mutant time-specific rescue experiments using the hsp16-2 promoter, synchronized worms were
grown until early L4 larva stage, when they received three heat shock pulses (30 min at 37˚C) with 2
hr resting intervals. Animals were analyzed the next morning at young adult stage.
Statistical analysis for HSN scorings
Data was categorically classified as ‘on’ or ‘off’ and the significance of the association was examined
using the two tailed Fisher’s exact test. For double mutant analysis, ‘phenotype’ vs. ‘no phenotype’
was compared and thus, ‘dim’ and ‘off’ were considered under the category ‘phenotype’. The null
hypothesis was that the level of expression in the double mutant would be equal to the product of
the levels of expression in single mutants (Mani et al., 2008). Whatever statistically deviated from
the expected, was considered genetic interaction; Pearson’s chi-squared test was used.
Immunohistochemistry
C. elegans serotonin antibody staining was performed using the tube fixation protocol
(McIntire et al., 1992). Briefly, synchronized young adult hermaphrodites were fixed in 4% parafor-
maldehyde (PFA) for 18 hr, with b-mercapto-ethanol for another 18 hr, with 1 mg/ml collagenase
(Sigma Aldrich, Merk, Darmstadt, Germany) for 90 min and incubated for 24 hr with rabbit anti-5HT
antibody (1:5000; Sigma Aldrich). Alexa 555-conjugated donkey anti-rabbit (1:500; Molecular
probes) was used as secondary antibody.
For mouse immunohistochemistry, freshly isolated E11.5 embryos from C57Bl/6JRccHsd were
fixed by immersion in 4% PFA. Rabbit anti-Sall2 (1:100; Sigma Aldrich), goat anti-Brn2 (1:100; Santa
Cruz Biotechnology, Santa Cruz, CA), rabbit anti-5HT (1:5000; Sigma Aldrich) and goat anti-5HT
(1:200; Abcam, Cambridge, UK) antibodies were used. As secondary antibodies Alexa 555-conju-
gated donkey anti-rabbit and anti-goat, and Alexa 488-conjugated donkey anti-rabbit and anti-goat
were used (1:600; Molecular probes, Invitrogen, Eugene, OR). Immunofluorescence samples were
analyzed and photographed using a confocal TCS-SP8 Leica microscope.
Promoter sequences required for the generation of transgenic lines
HSN early promoter was generated from tph-1prom2 in which we incidentally found a point muta-
tion that caused L1 expression:
GTAGTAAGCTCCGATGCGTTCCCGTTCATTATTCTTCTTCAATAAATTCGAA
ATCTGACATCATTCTCATCTTTTCCCATCATCACAAGCCGTGGGCTCATTTA
TTCTCCCACGGAAACCATGACAGCAAAAATAAATAGAGTGGCGCCTTATTC
GACTCATTTCGTTTTTTTTTCTCCGGATATTAGATTGTGTGGCAGGCGGCTC
CATTGTATATTcCGaaCCGAATTtttGAAGCACCACGCCATCGGATATCTAAAA
GAGGAGGTGTCTTTGTTTGCGCATAATAAAACAATCAATCAACACAGCAAA
GACCCCTCTCAACCTCATTTCATGATTTTCTTTGGTTTTTAGGTAGCATTGC
TCTCTTCAATCAT
* Mutated nucleotides with respect to tph-1prom2 are indicated in lowercase letters.
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RNAi experiments
RNAi experiments were performed by the standard feeding protocol (Kamath et al., 2003). rrf-3
(pk1426) background was used to sensitize worms to the RNAi effects. For maintenance experi-
ments, animals were grown under normal food (OP50) until young adult stage. At this stage we
scored tph-1::yfp and cat-1::MDM2::gfp expression in the HSN to confirm that all animals expressed
the fluorescent protein and then we transferred animals to RNAi plates with HT115 bacteria (Nova-
gen) transfected with RNAi clones. Worms were incubated at 15˚C for 72 hr and then HSN fluores-
cent expression was scored. For F1 RNAi scoring, we bleached gravid adults in OP50 plates, eggs
were allowed to hatch and worms grew in RNAi treated food. We scored their progeny, which had
developed under the embryonic effects of RNAi knock down (F1 scoring). The experiment was per-
formed in two independent replicates with similar results. As a negative control the L4440 empty
vector was used (pPD129.36, Addgene).
Electrophoretic mobility assays
Full-length unc-86 and ast-1 cDNA into the pET-21b His tag expression vector (EMD
Millipore, Merk) were kindly provided be Oliver Hobert. They were transformed into E. coli Rosetta2
(DE3) (Novagen) strain. Overexpression was done by first growing the cells at 37˚C in LB and Power
Broth medium (Molecular Dimensions) respectively, supplemented with 100 mg/ml ampicillin, 100
mg/ml chloramphenicol to OD600 = 0.5–0.6 and then inducing expression with 0.5 mM iso-propyl-
b-D thiogalactopyranoside (IPTG, Acros Organics, Thermo Fisher, Waltham, MA) at 37˚C for 3 hr or
20˚C for 16 hr, respectively.
UNC-86 protein was obtained as previously explained (Zhang et al., 2014) with minor changes.
Briefly, cells were collected by centrifugation and resuspended in buffer A (100 mM NaH2PO4,10
mM Tris [pH 7.5], 10% glycerol) supplemented with 1 mM phenylmethanesulfonyl fluoride (PMSF).
Cells were lysed by sonication. Soluble and insoluble fractions were separated by centrifugation and
analyzed by SDS/PAGE. Protein was substracted from insoluble fraction as follow: insoluble fraction
was resuspended in solubilization buffer (buffer A supplemented with 8 M urea) and loaded on a
pre-equilibrated His Trap HP column (GE Healthcare, Chicago, IL). The resin was washed with solubi-
lization buffer supplemented with 10 mM imidazole, and protein was eluted with the same buffer
supplemented with 500 mM imidazole. Elution buffer was exchanged by progressive dialysis to 20
mM HEPES [pH 7.5], 100 mM NaCl 10% glicerol, 2 mM MgCl2, and the protein was concentrated by
centrifugation up to 1.3 mg/ml and stored at  80˚C.
For AST-1 protein, cells were collected by centrifugation and resuspended in buffer B (200 mM
MES [pH 6.0], 500 mM NaCl, 2 mM MgCl2, 10% glycerol) supplemented with 1 mM PMSF. Cells
were lysed by sonication and soluble proteins were loaded on a His Trap HP column (GE Healthcare)
pre-equilibrated with buffer B. The resin was washed with buffer B supplemented with 10 mM imid-
azole, and protein was eluted with buffer B supplemented with 300 mM imidazole. Eluted fraction
was analyzed by SDS/PAGE. Imidazole was removed and protein concentrated by centrifugation up
to 0.3 mg/ul, and stored at  80˚C.
egl-18 cDNA was cloned into pcDNA.3 vector followed by His tag sequence and transfected with
Lipofectamine-2000 (Invitrogen) in HEK293T cells. HEK293T cells were grown in DMEM 10% FBS.
After 24 hr, cells were lysed with the following buffer: 1 mM EDTA, 0.5% Triton, 20 mM b-glicerolP,
0.2 mM PMSF, 100 mM Na3VO4 and protease inhibitor.
EMSAs were performed incubating UNC-86 and AST-1 proteins in a buffer containing 10 mM Tris
[pH 7.5], 50 mM NaCl, 1 mM MgCl2, 4% glycerol, 0.5 mM DTT, 0.5 mM EDTA, 1 mg of poly(dIdC), 6
mg of bovine serum albumin and labeled probes for 20 min at room temperature. For EGL-18, pro-
tein extracts were incubated in 20 mM Hepes, 50 mM NaCl, 5 mM MgCl2, 5% glycerol, 1 mM DTT,
0.1 mM EDTA, 1 mg of poly(dIdC), 6 mg of bovine serum albumin and 1 mg anti-6xhistag antibody
(Abcam) at 4˚C for 30 min. As negative control, anti-GFP antibody (Roche, Basel, Switzerland) was
used. Then, labeled probes were added and incubated for 20 min at room temperature. Finally, sam-
ples were loaded onto a 6% (37.5:1 acrylamide: bisacrylamide) gel and run at 150 V for 4 hr. Gels
were then dried and visualized using Fujifilm FLA-500. Probe sequences are listed in
Supplementary file 4. Primers were annealed and end-labeled with ATP [g 32P] (Perkin
Elmer, Waltham, MA) using T4 PNK (Thermo Scientific) according to the manufacturer’s
specifications.
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Bioinformatics analysis
Unless otherwise indicated, all the analyses were performed using R and Bioconductor (Huber et al.,
2015).
For C. elegans regulatory signature analysis, we built PWMs from the functional motifs found in
the 5HT pathway genes CRMs (Figure 5). Next, we downloaded upstream and intronic gene regions
from WormBase version 262 and classified genes in three groups: genes known to be expressed in
HSN, genes expressed in neurons and non-neuronal genes, according to WormBase annotations on
gene expression and/or belonging to the published neuronal genome (Hobert, 2013). PWMs were
aligned to genomic sequences and we retrieved matches with a minimum score of 70%. To increase
specificity, we removed all matches that did not bear an exact consensus sequence for the corre-
sponding TF family (ETS: YWTCCG, GATA: DGATAD, HLH: SCAGAA, INMS: CCSCWNNM, SPALT:
TTGTST, POU: WTKCAT). Then, we performed a sliding window search to find regions that included
at least one match for four or more of the 6 TF types. Windows were separated according to the
number of different motifs that they bore (4, 5 or 6), and then overlapping regions were merged.
Embryonic stem cell enhancers median size has been reported to be around 800 bp (Parker et al.,
2013); therefore, the initial search was performed with a maximum length restriction of either 600,
700 or 800 bp. Differences between HSN-expressed genes and other gene groups was greater
when the maximum length was set to 700 bp, thus we kept this maximum window length for the
rest of the analyses. To assess enrichment in signature in HSN-expressed genes we sampled 10,000
groups of 96 genes that (1) had not previously been reported to be expressed in the HSN, (2) at
least one ortholog had been described in other Caenorhabditis species (C. briggsae, C. japonica, C.
remanei or C. brenneri), and (3) such that their upstream and intronic regions were similar in length,
on average, to those of the HSN-expressed genes (Mann-Whitney U test, p-value>0.05). We com-
pared the distribution of the proportion of genes with signature (4, 5 or 6 different motifs) in these
groups to the HSN-expressed gene group. We consider the enrichment in signature to be significant
when the percentile of the HSN-expressed group is above 95. In order to assess signature conserva-
tion, we performed a similar motif search using other nematode genomes also available from Worm-
Base (C. briggsae, C. japonica, C. remanei, C. brenneri) and we considered the signature to be
conserved if HSN regulatory windows were found in all orthologous genes, at least 4, 5 or 6 motifs
for 4, 5 and 6-motif C. elegans windows.
Gene ontology analysis was performed using GOrilla software, using C. elegans coding genome
(19.276 genes) as control list (Eden et al., 2009).
For hierarchical clustering, we used curated data from WormBase (Hobert et al., 2016) to gener-
ate a matrix with gene expression profiles for the 118 C. elegans hermaphrodite anatomical neuronal
classes. Pan-neuronal genes and neurons in which less than 30 genes had been reported to be
expressed were excluded. We built a similar matrix with mouse gene expression data from RNA-seq
experiments, either from adult raphe nuclei divided into different rhombomeres (R1Dorsal, R1
Medial, R2, R3, R5, R6) (Guillemot and Hassan, 2017) or from cortical neurons that served as nega-
tive control (Molyneaux et al., 2015)). To transform the quantitative RNA-seq data into a presence-
absence binary matrix. We considered values above 19 CPM as present and values below that
threshold as absent because this cut-off produces a list of approximately 7000 expressed genes in
each Raphe sample (roughly a third of the genome that is what is being estimated as expressed in a
given cell type). Nevertheless, results were consistent in all conditions when considering cutoffs
ranging from 9 to 140 CPM, after which HSN-raphe cluster robustness started to decline (low AU
and BP values, not shown).
To assign mouse ortholgs to C. elegans genes, we combined orthology relationships between
mouse and worm genes annotated in the ENSEMBL database and worm-human orthology relation-
ships reported in Shaye and Greenwald (2011). In the last case, we used ENSEMBL database again
to assign mouse orthologs to human genes. In (Molyneaux et al., 2015)), ENSEMBL, OrthoMCL,
InParanoid and Homologene methods are combined to identify orthologs. Thus, we combined both
sources to have a wider coverage of orthology relationships than using ENSEMBL or
(Molyneaux et al., 2015) data alone. Worm genes without any mouse ortholog and genes that were
not expressed in any worm neuron were removed. Whenever a worm gene had more than one
mouse ortholog, it was duplicated in the worm data set. For hierarchical clustering, this binary matrix
containing mouse and worm expression data was fed to the pvclust function in the pvclust R
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package (Shimodaira, 2002), which uses a bootstrapping technique to calculate p-values for each
cluster, the AU and BP values (Shimodaira, 2002). Parameters were set as follows: method.hclust =
‘average’, method.dist= ‘binary’, nboot = 10,000, r = seq(0.5, 1.4, by = 0.1). The standard error of
the PV and AU values was approximately 0.1% for most clusters, including the HSN-raphe cluster.
Also, as a control, 100 random sets of 96 expressed genes (the same number of genes that are
expressed in the HSN) were generated from the worm gene pool. Each random set contained the
four 5HT pathway genes (tph-1, cat-1, cat-4 and bas-1) plus 92 randomly picked genes from the
genes expressed in C. elegans neurons. This data set was merged with mouse raphe nuclei expres-
sion profile and pvclust was run as before.
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